Global Hemodialysis & Peritoneal Dialysis Market Size, Share, and COVID-19 Impact Analysis, By Type (Hemodialysis and Peritoneal Dialysis), By Product (Device, Consumables, and Services), By End-Use (Home-based and Hospital-based), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 - 2032
Industry: HealthcareGlobal Hemodialysis & Peritoneal Dialysis Market Insights Forecasts to 2032
- The Global Hemodialysis & Peritoneal Dialysis Market Size was valued at USD 87.25 Billion in 2022.
- The Market Size is Growing at a CAGR of 7.4% from 2022 to 2032
- The Worldwide Hemodialysis & Peritoneal Dialysis Market Size is expected to reach USD 178.16 Billion by 2032
- Asia-Pacific is expected to grow higher during the forecast period
Get more details on this report -
The Global Hemodialysis & Peritoneal Dialysis Market Size is expected to reach USD 178.16 Billion by 2032, at a CAGR of 7.4% during the forecast period 2022 to 2032.
Market Overview
Hemodialysis and peritoneal dialysis are two forms of renal replacement therapies used to treat end-stage kidney disease. Hemodialysis involves the use of a machine called a dialyzer, which filters the blood to remove waste products and excess fluids. During hemodialysis, the patient's blood is pumped through the dialyzer, where it is cleaned before being returned to the body. In contrast, peritoneal dialysis uses the patient's peritoneal membrane as a natural filter. A special fluid called dialysate is introduced into the abdominal cavity, where it absorbs waste products and excess fluids from the blood through osmosis. The fluid is then drained, taking the waste products with it. Both hemodialysis and peritoneal dialysis have their advantages and considerations, and the choice between the two depends on factors such as the patient's medical condition, lifestyle, and personal preference.
Report Coverage
This research report categorizes the market for hemodialysis & peritoneal dialysis market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the hemodialysis & peritoneal dialysis market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the hemodialysis & peritoneal dialysis market.
Global Hemodialysis & Peritoneal Dialysis Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2022 |
Market Size in 2022 : | USD 87.25 Billion |
Forecast Period: | 2022-2032 |
Forecast Period CAGR 2022-2032 : | 7.4% |
2032 Value Projection: | USD 178.16 Billion |
Historical Data for: | 2018-2021 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 110 |
Segments covered: | By Type, By Product, By End-Use, By Region |
Companies covered:: | Baxter, B. Braun Melsungen AG, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co., Ltd., Nipro Corp., DaVita, BD, Nikkiso Co., Ltd., Cantel Medica |
Pitfalls & Challenges: | COVID-19 Empact,Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
Several drivers contribute to the growth of the hemodialysis and peritoneal dialysis market, the rising prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD) worldwide is a major driver. Additionally, the aging population, which is more susceptible to kidney-related disorders, is fueling the demand for dialysis treatments. Technological advancements in dialysis machines and improved dialysis techniques have also contributed to market growth. Furthermore, increasing healthcare expenditure, favorable reimbursement policies, and government initiatives to enhance access to dialysis services have boosted market expansion. The growing awareness regarding the benefits of early diagnosis and treatment of kidney diseases has led to an increased demand for dialysis procedures. Moreover, the preference for home-based dialysis therapies, such as peritoneal dialysis, due to convenience and cost-effectiveness, is driving market growth in this segment.
Restraining Factors
The hemodialysis and peritoneal dialysis market faces certain restraints. Limited accessibility to dialysis facilities, particularly in rural and underdeveloped regions, hampers the market growth. High treatment costs and the need for regular maintenance and monitoring also pose challenges, especially for patients with limited financial resources. Additionally, the potential risk of infection and associated complications with both hemodialysis and peritoneal dialysis procedures may deter some patients from opting for these treatments. Furthermore, the shortage of skilled healthcare professionals and trained staff capable of providing dialysis services may impede the market's expansion. Addressing these restraints requires concerted efforts to improve infrastructure, enhance affordability, and increase awareness among patients and healthcare providers.
Market Segmentation
- In 2022, the hemodialysis segment accounted for around 76.1% market share
On the basis of the type, the global hemodialysis & peritoneal dialysis market is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment has emerged as the dominant force in the hemodialysis and peritoneal dialysis market. Hemodialysis is a well-established and widely practiced method of renal replacement therapy. It has a long history of successful outcomes and is considered the standard treatment for end-stage renal disease (ESRD) in many regions. Additionally, hemodialysis offers certain advantages such as efficient removal of waste products and excess fluids, as well as the ability to rapidly stabilize patients in critical conditions. Moreover, technological advancements in hemodialysis machines, improved dialysis membranes, and enhanced monitoring systems have further strengthened the position of the hemodialysis segment. The availability of dedicated hemodialysis centers and the presence of trained healthcare professionals contribute to the widespread adoption of hemodialysis as the preferred choice for renal replacement therapy. Overall, the hemodialysis segment's dominance is a result of its proven efficacy, technological advancements, and widespread acceptance within the medical community.
- In 2022, the hospital-based segment dominated with more than 72.5% market share
Based on the end-use, the global hemodialysis & peritoneal dialysis market is segmented into home-based and hospital-based. The hospital-based segment has emerged as the dominant force in the hemodialysis and peritoneal dialysis market. There are several factors contributing to its dominance, because the hospitals have well-established infrastructure and specialized departments dedicated to providing dialysis services. They are equipped with advanced dialysis machines, trained healthcare professionals, and supportive medical staff, ensuring high-quality and comprehensive care for patients requiring dialysis. The hospitals often serve as referral centers for complex cases, attracting a larger patient pool and increasing the demand for dialysis treatments. Additionally, hospitals have the advantage of offering a wide range of medical services and specialties under one roof, facilitating multidisciplinary care and efficient coordination between different healthcare professionals. Moreover, hospitals often have established partnerships with dialysis machine manufacturers and suppliers, ensuring a consistent supply of equipment and consumables. Overall, the dominance of the hospital-based segment is a result of their comprehensive infrastructure, expertise, and ability to cater to a diverse patient population.
Regional Segment Analysis of the Hemodialysis & Peritoneal Dialysis Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America dominated the market with more than 37.5% revenue share in 2022.
Get more details on this report -
Based on region, North America has emerged as a dominant region in the hemodialysis and peritoneal dialysis market. Several factors contribute to this dominance, the region has a high prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD), leading to a significant demand for dialysis treatments. Additionally, the well-developed healthcare infrastructure, advanced medical technologies, and favorable reimbursement policies in North America support the growth of the market. The region also benefits from a large patient pool and a high awareness level regarding kidney diseases and available treatment options. Moreover, North America is home to major market players, including manufacturers of dialysis machines and providers of dialysis services. The presence of these key industry players and their continuous research and development activities further contribute to the region's market dominance in hemodialysis and peritoneal dialysis.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global hemodialysis & peritoneal dialysis market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Companies:
- Baxter
- B. Braun Melsungen AG
- Fresenius Medical Care AG
- Medtronic
- Asahi Kasei Medical Co., Ltd.
- Nipro Corp.
- DaVita
- BD
- Nikkiso Co., Ltd.
- Cantel Medical
Key Target Audience
- Market Players
- Investors
- End-Users
- Government Authorities
- Consulting and Research Firm
- Venture Capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In April 2022, The National Kidney Foundation (NKF) Innovation Fund provided the first dialysis grant to Kuleana Technology, Inc., a Seattle-based firm focusing on developing renal replacement therapy. Kuleana is developing ground-breaking portable hemodialysis equipment that does not require an external water source and does not require complex sorbents.
- In March 2022, Nipro Medical Corporation introduced the SURDIAL DX Hemodialysis System in the United States. The system is intended to provide patients and physicians with an ideal dialysis treatment experience. This launch has been expanded the product portfolio of the company as well as the customer base of the company.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global hemodialysis & peritoneal dialysis market based on the below-mentioned segments:
Hemodialysis & Peritoneal Dialysis Market, By Type
- Hemodialysis
- Peritoneal Dialysis
Hemodialysis & Peritoneal Dialysis Market, By Product
- Device
- Consumables
- Services
Hemodialysis & Peritoneal Dialysis Market, By End-Use
- Home-based
- Hospital-based
Hemodialysis & Peritoneal Dialysis Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Need help to buy this report?